Zobrazeno 1 - 3
of 3
pro vyhledávání: '"неоваскулярная возрастная макулярная дегенерация"'
Publikováno v:
Oftalʹmologiâ, Vol 19, Iss 3, Pp 658-664 (2022)
Purpose: To study long-term outcomes in neovascular age-related macular degeneration (nAMD) patients with low visual acuity and nonadherence to a treatment regimen of anti-vascular endothelial growth factor (VEGF) therapy.Patients and methods. In thi
Externí odkaz:
https://doaj.org/article/56b0649a0c5e4ec09cbe7f9537e33b47
Autor:
N. S. Zhajvoronok, V. V. Egorov, G. P. Smoliakova, L. P. Danilova, L. P. Emanova, D. A. Povalyaeva
Publikováno v:
Oftalʹmologiâ, Vol 16, Iss 4, Pp 508-514 (2019)
Purpose. Estimate of clinical efficacy of combined use of aflibercept and meldonium at tachyphylaxis of neovascular age-related macular degeneration (nAMD) to ranibizumab. Patients and methods. Comparative analysis of treatment results of nAMD in 25
Externí odkaz:
https://doaj.org/article/42bb32f6729240b3b442c61a63cea3ff
Autor:
R. R. Fayzrakhmanov
Publikováno v:
Российский офтальмологический журнал, Vol 12, Iss 2, Pp 97-105 (2019)
Antivasoproliferative therapy is a revolutionary trend in the treatment of neovascular age-related macular degeneration (nAMD), as it is aimed at blocking growth factors of the newly formed vessels. Currently, two anti-VEGF drugs are registered for o
Externí odkaz:
https://doaj.org/article/9368e32c50934e6cbfcad9d8b4aced03